Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Atea Pharmaceuticals, Inc. (AVIR) had Weighted-Average Shares Outstanding (Diluted) of 85.16M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-34.27M |
|
-- |
|
-- |
|
$39.04M |
|
$-39.04M |
|
$4.97M |
|
$-34.07M |
|
$-34.07M |
|
$-34.27M |
|
$-34.27M |
|
$-34.27M |
|
$-34.27M |
|
$-39.04M |
|
$-40.68M |
|
85.16M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
85.16M |
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$433.71M |
|
$0.77M |
|
$6.26M |
|
$439.96M |
|
$21.75M |
|
-- |
|
$7.13M |
|
$28.88M |
|
$411.08M |
|
$411.08M |
|
$411.08M |
|
85.58M |
|
| Cash Flow Statement Financials | |
$-30.56M |
|
$85.61M |
|
$-0.35M |
|
$64.70M |
|
$119.39M |
|
$54.70M |
|
$6.95M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
19.94 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-30.56M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-8.34% |
|
-8.34% |
|
-7.79% |
|
-8.34% |
|
$4.80 |
|
$-0.36 |
|
$-0.36 |
|